{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T18:06:58Z","timestamp":1785002818981,"version":"3.55.0"},"reference-count":44,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T00:00:00Z","timestamp":1276041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Echocardiography"],"published-print":{"date-parts":[[2010,9]]},"abstract":"<jats:p>Objective: Beh\u00e7et's disease is a chronic inflammatory vasculitis. Vascular involvement is one of the major complications of Beh\u00e7et's disease, during the course of the disease. Previous studies showed that ACE inhibitors and statins may improve endothelial functions in endothelial dysfunction. The aim of our study is to compare the effects of atorvastatin and lisinopril to placebo on endothelial dysfunction in patients with Beh\u00e7et's disease. Patients and methods: We prospectively studied 92 (48 female) Beh\u00e7et's patients who were diagnosed according to the International Study Group criteria. Endothelial dysfunction was evaluated by brachial artery flow\u2010mediated dilatation (FMD) method using high\u2010resolution vascular ultrasound device at baseline and after for 3\u2010month therapy. Patients were consecutively randomized into three groups as (atorvastatin (n = 31), lisinopril (n = 31), and placebo groups (n = 30). Patients in atorvastatin group received 20 mg atorvastatin, lisinopril group received 10 mg lisinopril per day, and placebo group received placebo per day for 3 months. Results: The baseline characteristics of patients were similar among three groups; however, high\u2010sensitive C\u2010reactive protein (hs\u2010CRP) levels were lower in atorvastatin group than placebo group. A significant improvement in FMD was observed in both atorvastatin (5.0 \u00b1 1.4 vs. 12.8 \u00b1 3.6%, P &lt; 0.001) and lisinopril groups (5.0 \u00b1 1.2 vs. 11.4 \u00b1 5.0%, P &lt; 0.001). Partial significant enhancement was observed in placebo group (4.9 \u00b1 1.1% vs. 5.7 \u00b1 1.0, P = 0.002). However, it was lower than the cutoff value for endothelial dysfunction. Conclusion: These findings suggest that atorvastatin and lisinopril improve endothelial functions in Beh\u00e7et's disease patients. However, large studies are needed to determine the long\u2010term effects of atorvastatin and lisinopril therapy. (Echocardiography 2010;27:997\u20101003)<\/jats:p>","DOI":"10.1111\/j.1540-8175.2010.01180.x","type":"journal-article","created":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T13:35:34Z","timestamp":1276090534000},"page":"997-1003","source":"Crossref","is-referenced-by-count":28,"title":["Effects of Atorvastatin and Lisinopril on Endothelial Dysfunction in Patients with Beh\u00e7et's Disease"],"prefix":"10.1111","volume":"27","author":[{"given":"Mehmet Tugrul","family":"Inanc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihat","family":"Kalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turgun","family":"Heyit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Ozdogru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Gungor","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haci Ahmet","family":"Kasapkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Gunebakmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Borlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikail","family":"Yarl\u0131oglues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurrahman","family":"Oguzhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,6,9]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.3109\/08830189709116846"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2003.11.039"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90896-5"},{"key":"e_1_2_7_5_2","first-page":"S19","article-title":"Neutrophil activation in Behcet's disease","volume":"19","author":"Eksioglu\u2010Demiralp E","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02505221"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2005.00477.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890701204866"},{"key":"e_1_2_7_9_2","first-page":"1544","article-title":"Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL\u20108 and increased neutrophil superoxide generation in Behcet's disease. A comparative study with familial Mediterranean fever and healthy subjects","volume":"20","author":"Mege JL","year":"1993","journal-title":"J Rheumatol"},{"key":"e_1_2_7_10_2","first-page":"247","article-title":"Auto\u2010oxidative damage in Behcet's disease\u2010endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils","volume":"49","author":"Niwa Y","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)01137-2"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06543.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91886-0"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.25.3227"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(00)00597-9"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8175.2007.00568.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0031-6997(25)06820-6","article-title":"Contribution of kinins to the cardiovascular actions of angiotensin\u2010converting enzyme inhibitors","volume":"47","author":"Linz W","year":"1995","journal-title":"Pharmacol Rev"},{"key":"e_1_2_7_18_2","first-page":"622","article-title":"Statin\u2010stimulated nitric oxide release from endothelium","volume":"7","author":"Dobrucki LW","year":"2001","journal-title":"Med Sci"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199502233320802"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.2174\/138161207780487566"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00783.2003"},{"key":"e_1_2_7_22_2","first-page":"1078","article-title":"Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-005-0590-1"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.043430"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.5.1314"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.21.5.804"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.37.24266"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc0702.104164"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.12.1129"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc3001.092039"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)05190-2"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc0802.104283"},{"key":"e_1_2_7_33_2","first-page":"46A","article-title":"Can lisinopril improve endothelial function in hyperlipidaemics?","volume":"29","author":"Lee AFC","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_7_34_2","first-page":"449","article-title":"Induction of angiotensin converting enzyme in the neointima after vascular injury: Possible role in restenosis","volume":"90","author":"Rakugi H","year":"1994","journal-title":"J Clin Invest"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00537-9"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.71.1.137"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2004.01382.x"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2009.31"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8175.2007.00475.x"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(02)01998-7"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.13.8.1125"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200401000-00008"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2003.01893.x"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.1997.38.6.428"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0449-1"}],"container-title":["Echocardiography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8175.2010.01180.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8175.2010.01180.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:11:18Z","timestamp":1740168678000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8175.2010.01180.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,9]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.1111\/j.1540-8175.2010.01180.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8175.2010.01180.x","archive":["Portico"],"relation":{},"ISSN":["0742-2822","1540-8175"],"issn-type":[{"value":"0742-2822","type":"print"},{"value":"1540-8175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,9]]}}}